Vocabulary knowledge as a reliable proxy of cognitive reserve in multiple sclerosis: a validation study.
- Published in:
- Neurological Sciences, 2024, v. 45, n. 8, p. 3931, doi. 10.1007/s10072-024-07388-w
- By:
- Publication type:
- Article
Works by Risi, Mario
Results: 6
1
2
Efficacy and safety of tixagevimab-cilgavimab (Evusheld®) in people with Multiple Sclerosis on Ocrelizumab: preliminary evidence.
- Published in:
- Neurological Sciences, 2023, v. 44, n. 11, p. 4107, doi. 10.1007/s10072-023-06975-7
- By:
- Publication type:
- Article
3
MOG-IgG testing strategies in accordance with the 2023 MOGAD criteria: a clinical-laboratory assessment.
- Published in:
- Journal of Neurology, 2024, v. 271, n. 5, p. 2840, doi. 10.1007/s00415-024-12180-z
- By:
- Publication type:
- Article
4
Cognitive reserve predicts long-term cognitive trajectories in relapsing-remitting multiple sclerosis.
- Published in:
- Multiple Sclerosis Journal, 2025, v. 31, n. 1, p. 107, doi. 10.1177/13524585241302167
- By:
- Publication type:
- Article
5
Humoral response to SARS-CoV-2 mRNA vaccine in patients with multiple sclerosis treated with natalizumab.
- Published in:
- 2021
- By:
- Publication type:
- Letter
6
Humoral response to SARS-CoV-2 mRNA vaccine in patients with multiple sclerosis treated with natalizumab.
- Published in:
- 2021
- By:
- Publication type:
- Letter